RxDoctor Payments Data

Darrin Hubert, MD

Plastic Surgery · Richmond, VANPI 1942366802

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medical Device Business Services, Inc. at 36.0% of the total. Reporting peaked in 2023 at $4,705 and has fallen 80.4% since, to $923 in 2025.

$10,617in general payments, 2019–2025

Across 129 payments — averaging $82.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$4K
  • Musculoskeletal Transplant Foundation Inc.$2K
  • Mentor Worldwide LLC$2K
  • Sientra, Inc.$1K
  • Vioptix Inc$719
  • Pacira Pharmaceuticals Incorporated$511
  • plus $1K from 9 others
$4,987in research payments, 2019–2025

Across 5 payments — averaging $997.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$4K
  • Mentor Worldwide LLC$800

What the payments were for

  • Consulting fees$3,82536%
  • Speaking & faculty fees$4805%
  • Food & beverage$6,31259%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,617 in reported general payments places this provider in the 80th percentile of 121 plastic surgery providers in Virginia.

See all plastic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$42,382
Medicare patients
56
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$179
Cefadroxil32$164

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →